Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Lesyk

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Cancers|August 29, 2024
The Proapoptotic Action of Pyrrolidinedione-Thiazolidinone Hybrids towards Human Breast Carcinoma Cells Does Not Depend on Their GenotypeNataliya Finiuk, Yuliia Kozak, Agnieszka Gornowicz, et al.
American Journal of Physiology. Cell Physiology|December 24, 2024
Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cellsOlga Klaudia Szewczyk-Roszczenko, Piotr Roszczenko, Anna Shmakova, et al.
International Journal of Molecular Sciences|April 23, 2022
2-{5-[(<i>Z</i>,2<i>Z</i>)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer MoleculeKamila Buzun, Agnieszka Gornowicz, Roman Lesyk, et al.
Archiv Der Pharmazie|September 15, 2022
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitorsJiri Rehulka, Ivanna Subtelna, Anna Kryshchyshyn-Dylevych, et al.
Bioorganic & Medicinal Chemistry|June 25, 2025
Synthesis and anticancer activity evaluation of new linked/fused bioisosteric pyrazole-thiazole-bearing hybrid moleculesIhor Yushyn, Serhii Holota, Nataliya Finiuk, et al.
Blood|November 17, 2020
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptorRuochen Jia, Thomas Balligand, Vasyl Atamanyuk, et al.
Cells|March 26, 2025
Juglone-Bearing Thiopyrano[2,3-d]thiazoles Induce Apoptosis in Colorectal Adenocarcinoma CellsYuliia Kozak, Nataliya Finiuk, Robert Czarnomysy, et al.
Bioorganic Chemistry|June 24, 2026
Targeting microtubule dynamics: synthesis and evaluation of novel 4-thiazolidinone derivatives in pancreatic CancerRostyslav Dudchak, Serhii Holota, Magdalena Podolak, et al.
International Journal of Nanomedicine|January 1, 2025
PEG-Polymeric Nanocarriers Alleviate the Immunosuppressive Effects of Free 4-Thiazolidinone-Based Chemotherapeutics on T Lymphocyte Function and Cytokine ProductionJana Tulinska, Lesya Kobylinska, Miroslava Lehotska Mikusova, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer AgentsIryna Ivasechko, Ihor Yushyn, Piotr Roszczenko, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Cancers|August 29, 2024
The Proapoptotic Action of Pyrrolidinedione-Thiazolidinone Hybrids towards Human Breast Carcinoma Cells Does Not Depend on Their GenotypeNataliya Finiuk, Yuliia Kozak, Agnieszka Gornowicz, et al.
American Journal of Physiology. Cell Physiology|December 24, 2024
Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cellsOlga Klaudia Szewczyk-Roszczenko, Piotr Roszczenko, Anna Shmakova, et al.
International Journal of Molecular Sciences|April 23, 2022
2-{5-[(<i>Z</i>,2<i>Z</i>)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer MoleculeKamila Buzun, Agnieszka Gornowicz, Roman Lesyk, et al.
Archiv Der Pharmazie|September 15, 2022
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitorsJiri Rehulka, Ivanna Subtelna, Anna Kryshchyshyn-Dylevych, et al.
Bioorganic & Medicinal Chemistry|June 25, 2025
Synthesis and anticancer activity evaluation of new linked/fused bioisosteric pyrazole-thiazole-bearing hybrid moleculesIhor Yushyn, Serhii Holota, Nataliya Finiuk, et al.
Blood|November 17, 2020
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptorRuochen Jia, Thomas Balligand, Vasyl Atamanyuk, et al.
Cells|March 26, 2025
Juglone-Bearing Thiopyrano[2,3-d]thiazoles Induce Apoptosis in Colorectal Adenocarcinoma CellsYuliia Kozak, Nataliya Finiuk, Robert Czarnomysy, et al.
Bioorganic Chemistry|June 24, 2026
Targeting microtubule dynamics: synthesis and evaluation of novel 4-thiazolidinone derivatives in pancreatic CancerRostyslav Dudchak, Serhii Holota, Magdalena Podolak, et al.
International Journal of Nanomedicine|January 1, 2025
PEG-Polymeric Nanocarriers Alleviate the Immunosuppressive Effects of Free 4-Thiazolidinone-Based Chemotherapeutics on T Lymphocyte Function and Cytokine ProductionJana Tulinska, Lesya Kobylinska, Miroslava Lehotska Mikusova, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer AgentsIryna Ivasechko, Ihor Yushyn, Piotr Roszczenko, et al.
Pageof 11